You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨財通證券:新華醫療盈利能力顯著提升 製藥裝備板塊新業務取得突破性進展
格隆匯5月9日丨近日,新華醫療(600587.SH)公佈2022年財報和2023年一季報。財通證券研報指出,公司業績持續高成長。醫療器械板塊在耗材佔比提升、新業務帶動和成本控制下,盈利能力顯著提升。其中,製藥裝備板塊新業務取得突破性進展。該行指出,新華醫療是山東國企改革重點公司。此前,公司推出了員工股權激勵,目標2022-2024年淨利潤不低於3.6億元、5.1億元、5.7億元,2022年業績完成情況遠高於股權激勵目標。同時,大股東以23.38元/股的價格大比例參與公司增發,員工的利益與股東利益綁定。預計公司2023-2025年實現營業收入99.98/110.19/121.38億元,歸母淨利潤6.86/8.79/10.58億元,對應PE分別為21/17/14倍,首次覆蓋,給予“增持”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account